Biocon Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on December 31, 2025
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biocon held an Extra-Ordinary General Meeting on December 31, 2025 at 2:30 PM IST via video conferencing, attended by 63 members and chaired by Executive Chairperson Kiran Mazumdar-Shaw. Six resolutions were placed before shareholders, covering: (1) an increase in the company's authorised share capital with a consequential amendment to the Memorandum of Association; (2) higher limits for investments, loans and guarantees under Section 186 of the Companies Act; (3) issuance of equity shares on a preferential basis for non-cash consideration; (4) raising funds in one or more tranches through equity shares and/or other securities; (5) grant of special rights to certain investors under SEBI LODR rules; and (6) material related party transactions between Biocon and Mylan Inc. (a related party of subsidiary Biocon Biologics). The meeting concluded at 3:29 PM IST. Remote e-voting was conducted from December 26-30, 2025, with additional e-voting available during the meeting.
The resolutions signal potential equity dilution (preferential share issuance and broader fund-raising plans) and a material related-party deal with Mylan Inc. tied to Biocon Biologics. Voting outcomes are still pending and will be announced within two working days, which will be the key trigger for any share-price reaction.